Institut Cancerologie De L'ouest
Clinical trials sponsored by Institut Cancerologie De L'ouest, explained in plain language.
-
Targeted attack on stomach cancer halted before it began
Disease control TerminatedThis study aimed to see if adding a new targeted drug, bemarituzumab, to standard chemotherapy could better treat certain stomach and gastroesophageal junction cancers before and after surgery. It was designed for patients whose cancer cells had high levels of a specific protein …
Phase: PHASE2 • Sponsor: Institut Cancerologie de l'Ouest • Aim: Disease control
Last updated Mar 20, 2026 14:48 UTC
-
Gentler breast reconstruction aims to ease shoulder pain
Symptom relief OngoingThis study is comparing two methods of breast reconstruction after mastectomy for breast cancer. It focuses on a newer technique that uses less back muscle, hoping to reduce shoulder pain and stiffness while still achieving a good cosmetic result. Researchers are tracking 200 pat…
Sponsor: Institut Cancerologie de l'Ouest • Aim: Symptom relief
Last updated Mar 02, 2026 15:26 UTC
-
Tracking motherhood after cancer: a landmark look at fertility outcomes
Knowledge-focused OngoingThis study aims to collect information on pregnancy, fertility preservation, and child health for women who had breast cancer before age 50. By reviewing the medical records of 22,000 women, researchers want to understand how cancer treatments affect family planning and pregnancy…
Sponsor: Institut Cancerologie de l'Ouest • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:34 UTC